Pfizer Files 2023 10-K, Details Fiscal Year Performance
Ticker: PFE · Form: 10-K · Filed: 2024-02-22T00:00:00.000Z
Sentiment: neutral
Topics: earnings, 10-K, pharmaceuticals
TL;DR
**Pfizer just dropped its 2023 10-K, giving us the full financial picture for the year.**
AI Summary
Pfizer Inc. filed its 10-K on February 22, 2024, for the fiscal year ending December 31, 2023. The company, identified by CIK 0000078003, is a pharmaceutical preparations company based in New York, NY. This filing provides an overview of its financial performance and operational status for the reported period.
Why It Matters
This filing provides crucial transparency into Pfizer's financial health and strategic direction, impacting investors, healthcare providers, and the global pharmaceutical market.
Risk Assessment
Risk Level: medium — As a large pharmaceutical company, Pfizer faces inherent risks related to drug development, regulatory approvals, and market competition, which are typically detailed in a 10-K.
Key Players & Entities
- PFIZER INC (company) — Filer of the 10-K
- 0000078003 (company) — Central Index Key (CIK) for Pfizer Inc.
- 20231231 (date) — Conformed Period of Report
- 20240222 (date) — Filed As Of Date
- New York (company) — City of Pfizer's business address
FAQ
What is the Central Index Key (CIK) for PFIZER INC?
The Central Index Key (CIK) for PFIZER INC is 0000078003.
When was the conformed period of report for this 10-K filing?
The conformed period of report for this 10-K filing was 20231231.
What is the Standard Industrial Classification (SIC) for PFIZER INC?
PFIZER INC's Standard Industrial Classification is PHARMACEUTICAL PREPARATIONS [2834].
What is the business address of PFIZER INC as listed in the filing?
The business address of PFIZER INC is 66 HUDSON BOULEVARD EAST, NEW YORK, NY 10001-2192.
When was this 10-K filed as of?
This 10-K was filed as of 20240222.
From the Filing
0000078003-24-000039.txt : 20240222 0000078003-24-000039.hdr.sgml : 20240222 20240222131737 ACCESSION NUMBER: 0000078003-24-000039 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 176 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240222 DATE AS OF CHANGE: 20240222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 24663684 BUSINESS ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 BUSINESS PHONE: 2127332323 MAIL ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 10-K 1 pfe-20231231.htm 10-K pfe-20231231 0000078003 2023 FY false P4Y http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2023#DebtCurrent http://fasb.org/us-gaap/2023#DebtCurrent http://fasb.org/us-gaap/2023#LongTermDebtNoncurrent http://fasb.org/us-gaap/2023#LongTermDebtNoncurrent http://fasb.org/us-gaap/2023#AccountsPayableCurrent http://fasb.org/us-gaap/2023#AccountsPayableCurrent 0 10 10 40 45 80 5 35 0% 10 10 20 45 70 15 35 0 5 95 100 P5Y P7Y P3Y P3Y P5Y P1Y P3Y P1Y P5Y P7Y P3Y P3Y 33 33 33 P3Y P3Y P3Y http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense 0000078003 2023-01-01 2023-12-31 0000078003 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0000078003 pfe:NotesDue20271.000Member 2023-01-01 2023-12-31 0000078003 2023-07-02 iso4217:USD 0000078003 2024-02-15 xbrli:shares 0000078003 2022-01-01 2022-12-31 0000078003 2021-01-01 2021-12-31 iso4217:USD xbrli:shares 0000078003 2023-12-31 0000078003 2022-12-31 0000078003 us-gaap:CommonStockMember 2020-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000078003 us-gaap:TreasuryStockCommonMember 2020-12-31 0000078003 us-gaap:RetainedEarningsMember 2020-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000078003 us-gaap:ParentMember 2020-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2020-12-31 0000078003 2020-12-31 0000078003 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000078003 us-gaap:ParentMember 2021-01-01 2021-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0000078003 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000078003 us-gaap:TreasuryStockCommonMember 2021-01-01 2021-12-31 0000078003 us-gaap:CommonStockMember 2021-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000078003 us-gaap:TreasuryStockCommonMember 2021-12-31 0000078003 us-gaap:RetainedEarningsMember 2021-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000078003 us-gaap:ParentMember 2021-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2021-12-31 0000078003 2021-12-3